Navigation Links
Most Employers Underestimate Full Costs of Employee Health on Productivity
Date:4/13/2009

ELK GROVE VILLAGE, Ill., April 13 /PRNewswire-USNewswire/ -- Poor health among workers is far costlier to U.S. employers than they realize, impacting their profitability and undercutting the nation's overall productivity, according to a major study published this week in the Journal of Occupational and Environmental Medicine (JOEM).

The multi-year study of ten organizations employing more than 150,000 workers indicates that employers who focus only on medical and pharmacy costs in creating employee health strategies may misidentify the health conditions that most impact the productivity of their employees -- while underestimating the impact of other factors.

One such factor, "presenteeism," occurs when employees with health conditions are present at their jobs but are unable to perform at full capacity. The study closely examined the effects of presenteeism, concluding that impaired employee-performance typically creates a greater drain on a company's productivity than employee absence -- a finding which could come as a surprise to some employers.

The study also found that when considering medical and drug costs alone, the top five conditions driving costs are cancer (other than skin cancer), back/neck pain, coronary heart disease, chronic pain, and high cholesterol. But when health-related productivity costs are measured along with medical and pharmacy costs, the top five chronic health conditions driving these overall health costs shift significantly, to depression, obesity, arthritis, back/neck pain and anxiety.

The study suggests that many employers miss an opportunity to improve productivity and their bottom-line results by failing to recognize and prioritize these health conditions when they develop integrated employee- health strategies and related interventions.

The study, coordinated by the American College of Occupational and Environmental Medicine (ACO
'/>"/>

SOURCE American College of Occupational and Environmental Medicine; Alere(R); Integrated Benefits Institute; National Pharmaceutical Council
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Newt Gingrich to Address Chicago Employers at Midwest Business Group on Healths 29th Annual Conference
2. Reducing Costs, Not Care: Medical Travel to New Zealand Can Help Alleviate Rising U.S. Healthcare Expenses for Insurers and Self-funded Employers
3. Thomson Reuters Study Finds Step Therapy Programs May Increase Overall Healthcare Costs for Employers
4. California Medical Association Names EMPLOYERS(R) Provider of Choice for its 35,000 Physician Members
5. S.C. BlueCross Issues National Walk at Lunch Day Challenge to Employers
6. Compassionate Friends Bereavement Organization Recognizes 141 Compassionate Employers Nationwide
7. Top Employers Find That in Tough Economic Times, a Healthy, Productive Workplace is More Important Than Ever
8. Influenza Infection Costs Employers Billions Each Year; Working Adults Largest Group Not Immunized Annually
9. Employers Support Non-Payment for Hospital-Acquired Infections
10. Tool Kit Helps Employers Team with Banks to Optimize Human Capital
11. Independence Blue Cross Motivates 60 Area Employers to Host National Walk @ Lunch Day Events on April 29

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...5/PRNewswire-USNewswire/--TheBlackAIDSInstituterec...iveleadershipfor2010. ,, ThenewBoardMembersarea...policy,law,finance,governmenthealthprograms,editor...romawiderangeofpersonalbackgroundsincludingbothhet...hemselves,andrepresentingmultipleagegroups. ,, ...
(Date:11/25/2009)...ndorsements,Business,andPressJoinEfforttoEducate ...-Onceagain,theNationalBipolarFoundationandtheMedic...Safe,tilStable"program,whichisnowbeingwidelyaccept....Today,theNationalBipolarFoundationreceivedaprocla...omtheLt.GovernorofLouisianaMitchLandrieu.TheNation...
(Date:11/25/2009)... evidence of a statistically significant survival ...se estrogen receptor (ER)-positive tumors had high...118 (ER-alpha S118-P), according to a brief commun...al of the National Cancer Institute . , Approxim...moxifen. Preclinical studies have shown that ER-al...
(Date:11/25/2009)...lood pressure? This simple question has been the ...ess-related gene Modulates High Blood Pressure in ... This simple question has been the focus of intens...or the first time established a link between a nov...e to stress in mice as well as humans. The studies...
(Date:11/25/2009)...to fight rheumatoid arthritis, could help newly di...SDAY, Nov. 25 (HealthDay News) -- A drug commonly ...d arthritis now also shows some promise in helping..., The drug, rituximab (Rituxan), helped patients ...ugh the disease had destroyed some of their pancre...
Breaking Medicine News(10 mins):Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3
.... 31 Biopure Corporation,(Nasdaq: BPUR ) announc...ommon stock will revert from BPURD to BPUR at the ... Outstanding warrants that trade on the OTCBB,will...re Corporation develops, manufactures and markets ...
.../PRNewswire-FirstCall/ - AEterna Zentaris Inc.,(TS...company focused on,endocrine therapy and oncology,...d operating results before market open on Wednesda...ants may,access the live webcast via the Company,s...
...ct. 31 Allos,Therapeutics, Inc. (Nasdaq: ALTH ),...pment and commercialization of small molecule ther...ced that Paul L. Berns, President and,CEO, will pr... (Eastern) on,Tuesday, November 6, 2007. There wil...
... a record $175 million; net book-to-bill of 1.7:1,...an all-time Company high, - Third quarter operat... - Third quarter EPS of $0.25 (GAAP) and $0.48...endle (Nasdaq: KNDL ), a,leading, global full-ser...
...DVENTRX Pharmaceuticals,Inc. (Amex: ANX ), a biop...used on commercializing proprietary product candid...seases, announced today that Evan M. Levine,ADVENT...The conference takes place in New York at the Wald...
...t. 30 Medical Services,International Inc. (OTC Pi...as added 4 additional distributors in the month of...utorships these corporations will have to purchase...,a Dengue Fever Kit and only one other manufacture...
Other Medicine News:Health News:Biopure's Stock Symbol Reverts to BPUR 2Health News:Allos Therapeutics to Present at the 2007 Acumen BioFin Rodman & Renshaw Conference 2Health News:Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007 2Health News:Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007 3Health News:Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007 4Health News:Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007 5Health News:Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007 6Health News:Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007 7Health News:Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007 8Health News:Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007 9Health News:ADVENTRX Pharmaceuticals to Present at the 18th Annual CIBC Healthcare Conference 2
(Date:11/25/2009)...5/PRNewswire/--Reportlinker.comannouncesthatanewma... IntranasalDrugDelivery-USMarketTrends&Analys...l-Drug-Delivery---US-Market-Trends--Analysis.html ...nganexpansionoftherapeuticapplicationsfromthedeliv...yofsystemictherapeuticdrugs.Thefutureofthetechnolo...
(Date:11/24/2009)...Nov.24/PRNewswire-Asia/--ChindexInternational,Inc....ricanproviderofWestern,healthcareproductsandservic...theCompanywillattendthe21stAnnualPiperJaffray,"Unp...09,atthe,NewYorkPalaceHotel. , Managementiscu...ember1,2009,andholdone-on-onemeetingsthroughoutthe...
(Date:11/24/2009)....,Nov.24/PRNewswire-FirstCall/--Vermillion,Inc.(VR...anofReorganizationandDisclosureStatementtoday,Nove...heDistrictofDelaware.Ahearingtoconsiderapprovaloft...er8,2009,withthehearingontheconfirmationofthePlans...Companytopayallclaimsinfull.ThePlanisexpected,ifap...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Chindex International to Present at Piper Jaffray Health Care Conference 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Music is the engine of new U M lab on a chip device 9321 1Music is the engine of new U M lab on a chip device 9321 2Stunting plants skyward reach could lead to improved yields 9318 1Stunting plants skyward reach could lead to improved yields 9318 2Public Health Experts Discuss Infectious Diseases Threats at News Conference 52432 1Public Health Experts Discuss Infectious Diseases Threats at News Conference 52432 2Public Health Experts Discuss Infectious Diseases Threats at News Conference 52432 3Public Health Experts Discuss Infectious Diseases Threats at News Conference 52432 4
...ns for treating returning vets and others exposed ... Schepens Eye Research Institute have shown for th...ause both eyes to lose a special protective abilit...ects the eye without the inflammation of the body,... delicate eye tissue. This finding, published in t...
...ExonHit Therapeutics,(Alternext: ALEHT) is pleased... lead compound in Alzheimer,s disease, is progress...l assessing EHT 0202 in patients with,Alzheimer,s ...tion of patient enrolment for the Phase IIa,repres...EHT 0202, and,provides a clear timeline for the re...
Other Medicine Technology:Laser Burn Injuries in One Eye Can Disrupt Protective Immune Privilege in Both Eyes, Study Finds 2ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 2ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 3ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 4
Naked Gold 20 nm
Naked Gold 20 nm - 50 OD
CranioFix2 Titanium Clamp System
...ate, reliable, portable, and easy-to-use pachymete... a dual-rechargeable battery system that makes cha...lution, color, touch screen controls make operatin...ent software simplifies calculating adjustments to...
Medicine Products: